PoniardNeoRx Corporation is changing its name to Poniard Pharmaceuticals, Inc. effective 5 p.m. PT June 16, 2006

Contact Us

Questions for the Investor Relations Department can be submitted through the form below. Fields marked with an * are required.

 
 
 
 
 
 
This helps Poniard Pharmaceuticals prevent automated submissions.
 

Stock Information
PARD - (NASD)
$2.52   - 0.37
Nov 21, 2008
4:00 PM ET

Quotes delayed at least 20 minutes. Information provided by eSignal.

About Poniard | Programs | Clinical Trials | Investors | News & Events | Contact